カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

動物由来免疫グロブリン製品の世界市場2022：IVIg液体、IVIgパウダー

◆英語タイトル：Global Animal-derived Immune Globulin Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC3744）◆商品コード：GIR22DC3744
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月
◆ページ数：98
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の動物由来免疫グロブリン製品市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の動物由来免疫グロブリン製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

動物由来免疫グロブリン製品市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・IVIg液体、IVIgパウダー

アプリケーション別セグメントは次のように区分されます。
・免疫不全、自己免疫疾患、急性感染症

世界の動物由来免疫グロブリン製品市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、動物由来免疫グロブリン製品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な動物由来免疫グロブリン製品メーカーの企業概要、2019年～2022年までの動物由来免疫グロブリン製品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な動物由来免疫グロブリン製品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別動物由来免疫グロブリン製品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの動物由来免疫グロブリン製品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での動物由来免疫グロブリン製品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および動物由来免疫グロブリン製品の産業チェーンを掲載しています。
・第13、14、15章では、動物由来免疫グロブリン製品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 動物由来免疫グロブリン製品の概要
– 種類別分析（2017年vs2021年vs2028年）：IVIg液体、IVIgパウダー
– 用途別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症
– 世界の動物由来免疫グロブリン製品市場規模・予測
– 世界の動物由来免疫グロブリン製品生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：IVIg液体、IVIgパウダー
・用途別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症
・動物由来免疫グロブリン製品の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・動物由来免疫グロブリン製品のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・動物由来免疫グロブリン製品のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・動物由来免疫グロブリン製品の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・動物由来免疫グロブリン製品の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Animal-derived Immune Globulin Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Animal-derived Immune Globulin Products Market Size & Forecast
1.4.1 Global Animal-derived Immune Globulin Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Animal-derived Immune Globulin Products Sales in Volume (2017-2028)
1.4.3 Global Animal-derived Immune Globulin Products Price (2017-2028)
1.5 Global Animal-derived Immune Globulin Products Production Capacity Analysis
1.5.1 Global Animal-derived Immune Globulin Products Total Production Capacity (2017-2028)
1.5.2 Global Animal-derived Immune Globulin Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal-derived Immune Globulin Products Market Drivers
1.6.2 Animal-derived Immune Globulin Products Market Restraints
1.6.3 Animal-derived Immune Globulin Products Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Animal-derived Immune Globulin Products Product and Services
2.1.4 Pfizer Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Rare Disease Therapeutics
2.2.1 Rare Disease Therapeutics Details
2.2.2 Rare Disease Therapeutics Major Business
2.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product and Services
2.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Instituto Bioclon
2.3.1 Instituto Bioclon Details
2.3.2 Instituto Bioclon Major Business
2.3.3 Instituto Bioclon Animal-derived Immune Globulin Products Product and Services
2.3.4 Instituto Bioclon Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co Animal-derived Immune Globulin Products Product and Services
2.4.4 Merck & Co Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Animal-derived Immune Globulin Products Product and Services
2.5.4 Sanofi Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Protherics
2.6.1 Protherics Details
2.6.2 Protherics Major Business
2.6.3 Protherics Animal-derived Immune Globulin Products Product and Services
2.6.4 Protherics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Genzyme Corporation
2.7.1 Genzyme Corporation Details
2.7.2 Genzyme Corporation Major Business
2.7.3 Genzyme Corporation Animal-derived Immune Globulin Products Product and Services
2.7.4 Genzyme Corporation Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Animal-derived Immune Globulin Products Breakdown Data by Manufacturer
3.1 Global Animal-derived Immune Globulin Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Animal-derived Immune Globulin Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Animal-derived Immune Globulin Products
3.4 Market Concentration Rate
3.4.1 Top 3 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.4.2 Top 6 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.5 Global Animal-derived Immune Globulin Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Animal-derived Immune Globulin Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal-derived Immune Globulin Products Market Size by Region
4.1.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
4.1.2 Global Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
4.2 North America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.3 Europe Animal-derived Immune Globulin Products Revenue (2017-2028)
4.4 Asia-Pacific Animal-derived Immune Globulin Products Revenue (2017-2028)
4.5 South America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.6 Middle East and Africa Animal-derived Immune Globulin Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Animal-derived Immune Globulin Products Sales in Volume by Type (2017-2028)
5.2 Global Animal-derived Immune Globulin Products Revenue by Type (2017-2028)
5.3 Global Animal-derived Immune Globulin Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Animal-derived Immune Globulin Products Sales in Volume by Application (2017-2028)
6.2 Global Animal-derived Immune Globulin Products Revenue by Application (2017-2028)
6.3 Global Animal-derived Immune Globulin Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
7.2 North America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
7.3 North America Animal-derived Immune Globulin Products Market Size by Country
7.3.1 North America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
7.3.2 North America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal-derived Immune Globulin Products Sales by Type (2017-2028)
8.2 Europe Animal-derived Immune Globulin Products Sales by Application (2017-2028)
8.3 Europe Animal-derived Immune Globulin Products Market Size by Country
8.3.1 Europe Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2017-2028)
9.2 Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2017-2028)
9.3 Asia-Pacific Animal-derived Immune Globulin Products Market Size by Region
9.3.1 Asia-Pacific Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
10.2 South America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
10.3 South America Animal-derived Immune Globulin Products Market Size by Country
10.3.1 South America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
10.3.2 South America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2017-2028)
11.2 Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2017-2028)
11.3 Middle East & Africa Animal-derived Immune Globulin Products Market Size by Country
11.3.1 Middle East & Africa Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Animal-derived Immune Globulin Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Animal-derived Immune Globulin Products
12.3 Animal-derived Immune Globulin Products Production Process
12.4 Animal-derived Immune Globulin Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Animal-derived Immune Globulin Products Typical Distributors
13.3 Animal-derived Immune Globulin Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Animal-derived Immune Globulin Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Animal-derived Immune Globulin Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Animal-derived Immune Globulin Products Product and Services
Table 6. Pfizer Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Rare Disease Therapeutics Major Business
Table 9. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product and Services
Table 10. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Instituto Bioclon Basic Information, Manufacturing Base and Competitors
Table 12. Instituto Bioclon Major Business
Table 13. Instituto Bioclon Animal-derived Immune Globulin Products Product and Services
Table 14. Instituto Bioclon Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co Major Business
Table 17. Merck & Co Animal-derived Immune Globulin Products Product and Services
Table 18. Merck & Co Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Animal-derived Immune Globulin Products Product and Services
Table 22. Sanofi Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Protherics Basic Information, Manufacturing Base and Competitors
Table 24. Protherics Major Business
Table 25. Protherics Animal-derived Immune Globulin Products Product and Services
Table 26. Protherics Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 28. Genzyme Corporation Major Business
Table 29. Genzyme Corporation Animal-derived Immune Globulin Products Product and Services
Table 30. Genzyme Corporation Animal-derived Immune Globulin Products Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Animal-derived Immune Globulin Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 32. Global Animal-derived Immune Globulin Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Animal-derived Immune Globulin Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Animal-derived Immune Globulin Products Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and Animal-derived Immune Globulin Products Production Site of Key Manufacturer
Table 36. Animal-derived Immune Globulin Products New Entrant and Capacity Expansion Plans
Table 37. Animal-derived Immune Globulin Products Mergers & Acquisitions in the Past Five Years
Table 38. Global Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 39. Global Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 40. Global Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 43. Global Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 44. Global Animal-derived Immune Globulin Products Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Animal-derived Immune Globulin Products Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Animal-derived Immune Globulin Products Price by Type (2017-2022) & (USD/Kg)
Table 47. Global Animal-derived Immune Globulin Products Price by Type (2023-2028) & (USD/Kg)
Table 48. Global Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 49. Global Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 50. Global Animal-derived Immune Globulin Products Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Animal-derived Immune Globulin Products Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Animal-derived Immune Globulin Products Price by Application (2017-2022) & (USD/Kg)
Table 53. Global Animal-derived Immune Globulin Products Price by Application (2023-2028) & (USD/Kg)
Table 54. North America Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 55. North America Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 56. North America Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 59. North America Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 60. North America Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 61. North America Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 62. Europe Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 63. Europe Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 64. Europe Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 67. Europe Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 68. Europe Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 69. Europe Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 70. Asia-Pacific Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 71. Asia-Pacific Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 72. Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 75. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 76. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 77. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 78. South America Animal-derived Immune Globulin Products Sales by Country (2017-2022) & (MT)
Table 79. South America Animal-derived Immune Globulin Products Sales by Country (2023-2028) & (MT)
Table 80. South America Animal-derived Immune Globulin Products Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Animal-derived Immune Globulin Products Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 83. South America Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 84. South America Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 85. South America Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 86. Middle East & Africa Animal-derived Immune Globulin Products Sales by Region (2017-2022) & (MT)
Table 87. Middle East & Africa Animal-derived Immune Globulin Products Sales by Region (2023-2028) & (MT)
Table 88. Middle East & Africa Animal-derived Immune Globulin Products Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Animal-derived Immune Globulin Products Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2017-2022) & (MT)
Table 91. Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2023-2028) & (MT)
Table 92. Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2017-2022) & (MT)
Table 93. Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2023-2028) & (MT)
Table 94. Animal-derived Immune Globulin Products Raw Material
Table 95. Key Manufacturers of Animal-derived Immune Globulin Products Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Animal-derived Immune Globulin Products Typical Distributors
Table 99. Animal-derived Immune Globulin Products Typical Customers
List of Figures
Figure 1. Animal-derived Immune Globulin Products Picture
Figure 2. Global Animal-derived Immune Globulin Products Revenue Market Share by Type in 2021
Figure 3. IVIg Liquid
Figure 4. IVIg Powder
Figure 5. Global Animal-derived Immune Globulin Products Revenue Market Share by Application in 2021
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Animal-derived Immune Globulin Products Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Animal-derived Immune Globulin Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Animal-derived Immune Globulin Products Sales (2017-2028) & (MT)
Figure 12. Global Animal-derived Immune Globulin Products Price (2017-2028) & (USD/Kg)
Figure 13. Global Animal-derived Immune Globulin Products Production Capacity (2017-2028) & (MT)
Figure 14. Global Animal-derived Immune Globulin Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Animal-derived Immune Globulin Products Market Drivers
Figure 16. Animal-derived Immune Globulin Products Market Restraints
Figure 17. Animal-derived Immune Globulin Products Market Trends
Figure 18. Global Animal-derived Immune Globulin Products Sales Market Share by Manufacturer in 2021
Figure 19. Global Animal-derived Immune Globulin Products Revenue Market Share by Manufacturer in 2021
Figure 20. Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Animal-derived Immune Globulin Products Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Animal-derived Immune Globulin Products Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 24. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 25. North America Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 26. Europe Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 28. South America Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Animal-derived Immune Globulin Products Revenue (2017-2028) & (USD Million)
Figure 30. Global Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 31. Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2017-2028)
Figure 32. Global Animal-derived Immune Globulin Products Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 34. Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2017-2028)
Figure 35. Global Animal-derived Immune Globulin Products Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 37. North America Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 38. North America Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 39. North America Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 40. United States Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 44. Europe Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 45. Europe Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 46. Europe Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 47. Germany Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 56. China Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 63. South America Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 64. South America Animal-derived Immune Globulin Products Sales Market Share by Country (2017-2028)
Figure 65. South America Animal-derived Immune Globulin Products Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Animal-derived Immune Globulin Products Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Animal-derived Immune Globulin Products Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Animal-derived Immune Globulin Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin Products in 2021
Figure 77. Manufacturing Process Analysis of Animal-derived Immune Globulin Products
Figure 78. Animal-derived Immune Globulin Products Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 動物由来免疫グロブリン製品の世界市場2022：IVIg液体、IVIgパウダー(Global Animal-derived Immune Globulin Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 筋注用免疫グロブリン製剤の世界市場2022：10mLバイアル、2.0mLバイアル
  • 静注用人免疫グロブリン製剤の世界市場2022：液状IVIg、粉末状IVIg
  • 人免疫グロブリン静注の世界市場2022：液状IVIg、粉末状IVIg

    • ◆H&Iグローバルリサーチのお客様（例）◆